Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose– response meta-analysis
Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose– response meta-analysis
نویسندگان: مهدیه عباسعلیزاد فرهنگی , مهدی وجدی , محمد اصغری جعفرآبادی
کلمات کلیدی: Stroke, Trimethylamine N-oxide (TMAO), Observational studies, Dose-response analysis, Gut microbiota
metabolite, Risk factor
نشریه: 25855 , 1 , 19 , 2020
| نویسنده ثبت کننده مقاله |
مهدیه عباسعلیزاد فرهنگی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات پزشکی مبتنی بر شواهد EBM |
| کد مقاله |
73040 |
| عنوان فارسی مقاله |
Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose– response meta-analysis |
| عنوان لاتین مقاله |
Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose– response meta-analysis |
| ناشر |
3 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
متاآنالیز |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Aims: Several epidemiological studies have examined the association between trimethylamine N-Oxide (TMAO) and
stroke risk; however, the results are still inconclusive. The purpose of this meta-analysis was to evaluate the
relationship between TMAO concentrations and stroke risk.
Methods: PubMed, Scopus, Cochrane and ProQuest search engines were systematically searched up to 18 June
2019. All of the studies that evaluated the relationship between TMAO and stroke were included in the systematic
review and eligible studies were included into the meta-analysis. Meta-regression and subgroup analysis were also
employed to find the source of heterogeneity.
Results: Eight studies (two cross-sectional studies, two cohort studies, three case-control studies and one nested
case-control study) with a total of 6150 participants were included in the meta-analysis. The overall result showed
that being in the highest category of TMAO increased the odds of stroke by 68% (OR: 1.675; CI: 0.866–3.243; P =
0.047) and mean TMAO concentrations was 2.201 μmol/L higher in patients with stroke rather than non-stroke
controls (weighted mean difference (WMD): 2.20; CI: 1.213–3.188; P < 0.001). Furthermore, we observed revealed a
non-linear association between increased TMAO levels and increased odds of stroke (P- for nonlinearity < 0.001). In
addition, visual inspection of the funnel plot revealed a significant asymmetry among studies examining the
differences in TMAO in patients with stroke versus control group.
Conclusion: This is the first meta-analysis to show positive dose-dependent relations between circulating TMAO
concentration and stroke risk. However, further interventional studies and long-term studies are needed to better
explain causality. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| TMAO-stroke.pdf | 1399/05/10 | 1216095 | دانلود |